Men all over the country are likely rejoicing that the U.S. Food and Drug Administration (FDA) has okayed the release of a female libido pill, called Addyi (flibanserin)! The drug is supposed to crank up the desire for sex in women, allowing them to join men in having a little pill available for better sex. It is a psychiatric drug that is said to impact a woman’s chemicals in the brain that regulate mood and appetite and must be taken on a daily basis.
The problem with Addyi is that the pill increases risks of dangerous low blood pressure and fainting. These risks are worsened when the pill is taken while simultaneously consuming alcohol or taking other prescribed medications. The FDA, in fact, rejected Addyi on two different occasions in 2010 and 2013 for these side effects, as well as the side effects of drowsiness, dizziness, and nausea. The FDA states that if patients find the Addyi is not helping their libido in eight weeks after starting its use, they should discontinue it since the risks would outweigh the benefits.
The bottom line, as always, is that every consumer must weigh benefits and risks with prescribed medications. The patient and doctor must ask whether the benefit of a possible reduction in emotional stress (with low libido) is worth the potentially dangerous risks. This decision could be made easier by the fact that trials of the drug showed women had a single extra sexual encounter per month with daily use of the drug. Inserra & Kelley Law Offices desires the utmost health and safety for all of you out there and is here to answer your questions as to whether you may be due compensation for unfortunate injuries to you or your loved ones. Therefore, consult your doctor about whether this drug is right for you and stay tuned for further information about how the risks weigh out as the drug gets officially released and prescribed.